Wednesday, September 2, 2020

Gene therapy: Novel targets for congenital blindness

Retinitis pigmentosa is the most prevalent form of congenital blindness. Using a retinitis pigmentosa mouse model, researchers have now shown that targeted activation of genes of similar function can compensate for the primary defect.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/09/200902095134.htm

No comments:

Post a Comment